I'm excited to start our advisory board, with the appointment of Dr. Mark Boguski. Since our initial financing in 2005, our investors have urged us to build the science advisory board. So what took so long? Until now, it wasn't necessary. We provided clear business value to pharma for a well-defined use case. An advisory board ...
The Next Generation Sequencing Data Analysis conference in Providence in September looks like it's shaping up to be a good one. Plenty of GenomeQuesters will be there as will I. We're sponsoring a roundtable - NGS Five Years Down The Road. In five years time, NGS will have gone from "sexy new technology" to "established ...
The past few weeks have been exciting! The rush of users to the 6.0Beta product has kept us on our toes trying to ensure that everyone can find their way around. Our users' ingenuity is thrilling to watch. The heart of the company beats in rhythm with users who take a few hundred million reads in ...
I was recently interviewed for an article by Kevin Davies at Bio-IT World on our GenomeQuest 6.0Beta launch. He immediately connected our story to "NGS" and "Cloud" computing. We have deliberately not over-played the "cloud" aspect of our offering, but as the response from the article shows, there is a lot of interest in the ...